HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does high-density lipoprotein protect vascular function in healthy pregnancy?

Abstract
The maternal adaptation to pregnancy includes hyperlipidaemia, oxidative stress and chronic inflammation. In non-pregnant individuals, these processes are usually associated with poor vascular function. However, maternal vascular function is enhanced in pregnancy. It is not understood how this is achieved in the face of the adverse metabolic and inflammatory environment. Research into cardiovascular disease demonstrates that plasma HDL (high-density lipoprotein), by merit of its functionality rather than its plasma concentration, exerts protective effects on the vascular endothelium. HDL has vasodilatory, antioxidant, anti-thrombotic and anti-inflammatory effects, and can protect against endothelial cell damage. In pregnancy, the plasma HDL concentration starts to rise at 10 weeks of gestation, peaking at 20 weeks. The initial rise in plasma HDL occurs around the time of the establishment of the feto-placental circulation, a time when the trophoblast plugs in the maternal spiral arteries are released, generating oxidative stress. Thus there is the intriguing possibility that new HDL of improved function is synthesized around the time of the establishment of the feto-placental circulation. In obese pregnancy and, to a greater extent, in pre-eclampsia, plasma HDL levels are significantly decreased and maternal vascular function is reduced. Wire myography studies have shown an association between the plasma content of apolipoprotein AI, the major protein constituent of HDL, and blood vessel relaxation. These observations lead us to hypothesize that HDL concentration, and function, increases in pregnancy in order to protect the maternal vascular endothelium and that in pre-eclampsia this fails to occur.
AuthorsWan N Wan Sulaiman, Muriel J Caslake, Christian Delles, Helen Karlsson, Monique T Mulder, Delyth Graham, Dilys J Freeman
JournalClinical science (London, England : 1979) (Clin Sci (Lond)) Vol. 130 Issue 7 Pg. 491-7 (Apr 01 2016) ISSN: 1470-8736 [Electronic] England
PMID26888561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2016 Authors; published by Portland Press Limited.
Chemical References
  • APOA1 protein, human
  • Apolipoprotein A-I
  • Inflammation Mediators
  • Lipoproteins, HDL
Topics
  • Adaptation, Physiological
  • Animals
  • Apolipoprotein A-I (blood)
  • Blood Vessels (metabolism, physiopathology)
  • Energy Metabolism
  • Female
  • Humans
  • Inflammation Mediators (blood)
  • Lipoproteins, HDL (blood)
  • Maternal-Fetal Exchange
  • Oxidative Stress
  • Placental Circulation
  • Pre-Eclampsia (blood, physiopathology, prevention & control)
  • Pregnancy
  • Pregnancy Complications, Cardiovascular (blood, physiopathology, prevention & control)
  • Vasodilation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: